Eisai files for Japan approval of Alzheimer's drug - Nikkei Asia
Drugmaker's move follows U.S. application for full FDA approval
(Reuters) -- Japanese drugmaker Eisai said on Monday it had submitted a marketing authorization application in Japan for its Alzheimer's drug lecanemab, which was recently granted accelerated approva… [+727 chars]
Read More
Other Stories in Business
- 3 Things: Tariffs, Bear Markets And Inflation
- DOGE's anti-DEI drive flagged these programs. Only they weren't DEI.
- Fun and Immersive Experience awaits visitors
- Ray Dalio Cites 1930s Germany to Assess Unfolding Trade War
- DOGE's anti-DEI drive flagged these programs. Only they weren't DEI.
- Alibaba's Accio Hits 1 Million Users, Unveiling New AI Features to Empower SMEs in Global Trade
- Alibaba's Accio Hits 1 Million Users, Unveiling New AI Features to Empower SMEs in Global Trade
- Eos Energy (EOSE): Sell On Debt Covenant Issues, Execution Risks And Elevated Valuation
- 202 lokasi PJRM di Negeri Sembilan sempena Ramadan - KPDN
